Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06420115

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
580 (estimated)
Sponsor
University Hospital Padova · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer

Detailed description

To assess whether a larger caliber (16G) prostate biopsy needle increases the diagnostic capability of prostate neoplasia compared to a smaller caliber (18G) needle, while keeping perioperative complications constant.

Conditions

Interventions

TypeNameDescription
DEVICEdifferent needle size for prostate biopsyMRI Fusion Transperineal Prostate Biopsy

Timeline

Start date
2024-06-01
Primary completion
2025-12-01
Completion
2026-05-30
First posted
2024-05-17
Last updated
2025-03-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06420115. Inclusion in this directory is not an endorsement.

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects (NCT06420115) · Clinical Trials Directory